Patient-reported outcomes measures (PROMs) and patient-reported experience measures (PREMs) of COVID-19 telerehabilitation: Prospective pilot program
- PMID: 35945781
- PMCID: PMC9351514
- DOI: 10.1097/MD.0000000000029639
Patient-reported outcomes measures (PROMs) and patient-reported experience measures (PREMs) of COVID-19 telerehabilitation: Prospective pilot program
Abstract
Telemedicine is proving to be a useful tool in the telemonitoring of respiratory patients and telerehabilitation programs. The use of telemedicine has been proposed by the main medical societies because of the limited resources and the healthcare workers infection risk in the Coronavirus Disease 2019 (COVID-19) pandemic. The aim of this pilot program is to evaluate the feasibility of COVID-19 telerehabilitation program from the hospital to the home with clinical, functional and patient satisfaction outcomes. Rehabilitation was initiated in the hospital by a physiotherapist and complemented by "Estoi" (a mobile application), which was continued at home with telemonitoring and messaging with the medical team. Patients' habitual use of smartphones was not queried for inclusion. Sixteen patients were consecutively enrolled, 47% women with a mean age of 63 years old. 50% of patients completed ≥15 rehabilitation sessions. In total, 88% of patients referred that the mobile application incentive them to do more physical therapy, and 63% would choose telerehabilitation instead of center-based rehabilitation for new rehabilitation programs. Patient satisfaction (0-10) for the mobile application was 8.4 and 8.9 for the telerehabilitation program. Beginning telerehabilitation in the hospital could increase the efficacy and efficiency of physical therapy, which is safe for patients and healthcare workers. Following at home, this telerehabilitation program seems to encourage and empower patients who have reported high satisfaction. Further randomized studies with larger numbers of patients and multicenter studies are required to evaluate these results.
Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
Conflict of interest: Jaume Bordas-Martinez has participated in the development of the smartphone application. All the other authors have nothing to disclose.
Similar articles
-
Safety, feasibility and initial efficacy of an app-facilitated telerehabilitation (AFTER) programme for COVID-19 survivors: a pilot randomised study.BMJ Open. 2022 Jul 26;12(7):e061285. doi: 10.1136/bmjopen-2022-061285. BMJ Open. 2022. PMID: 35882451 Free PMC article. Clinical Trial.
-
Home-based telerehabilitation is not inferior to a centre-based program in patients with chronic heart failure: a randomised trial.J Physiother. 2017 Apr;63(2):101-107. doi: 10.1016/j.jphys.2017.02.017. Epub 2017 Mar 14. J Physiother. 2017. PMID: 28336297 Clinical Trial.
-
Is Telerehabilitation a Safe and Viable Option for Patients with COPD? A Feasibility Study.COPD. 2015 Apr;12(2):217-25. doi: 10.3109/15412555.2014.933794. Epub 2014 Aug 5. COPD. 2015. PMID: 25093419 Clinical Trial.
-
The neurogenic dysphagia management via telemedicine: a systematic review.Eur J Phys Rehabil Med. 2022 Apr;58(2):179-189. doi: 10.23736/S1973-9087.21.06921-5. Epub 2021 Oct 4. Eur J Phys Rehabil Med. 2022. PMID: 34605620 Free PMC article.
-
Pulmonary Rehabilitation in a Post-COVID-19 World: Telerehabilitation as a New Standard in Patients with COPD.Int J Chron Obstruct Pulmon Dis. 2021 Feb 19;16:379-391. doi: 10.2147/COPD.S263031. eCollection 2021. Int J Chron Obstruct Pulmon Dis. 2021. PMID: 33642858 Free PMC article. Review.
Cited by
-
Effectiveness of Telemedicine for Musculoskeletal Disorders: Umbrella Review.J Med Internet Res. 2024 Feb 2;26:e50090. doi: 10.2196/50090. J Med Internet Res. 2024. PMID: 38306156 Free PMC article.
References
-
- Lambert TE, Harvey LA, Avdalis C, et al. . An app with remote support achieves better adherence to home exercise programs than paper handouts in people with musculoskeletal conditions: a randomised trial. J Physiother. 2017;63:161–7. - PubMed